Tg Therapeutics reported $231.79M in Cash and Equivalent for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Amgen AMGN:US $ 5203M 1325M
Ardelyx ARDX:US $ 50.43M 10.91M
Arrowhead Research ARWR:US $ 139.44M 53.03M
Bayer BAYN:GR € 3412M 2373M
Biogen BIIB:US $ 2646.6M 897.3M
Corcept Therapeutics CORT:US $ 35.35M 26.52M
Curis CRIS:US $ 34.01M 15.54M
Dynavax Technologies DVAX:US $ 249.09M 69.67M
Gilead Sciences GILD:US $ 7000M 2704M
Infinity Pharmaceuticals INFI:US $ 45.84M 7.29M
Intercept Pharmaceuticals ICPT:US $ 58.02M 9.7M
Karyopharm Therapeutics KPTI:US $ 82.25M 71.01M
Novartis NOVN:VX SF 3625M 10227M
Novavax NVAX:US $ 1375.59M 195.37M
Ptc Therapeutics PTCT:US $ 158.16M 13.98M
Puma Biotechnology PBYI:US $ 52.76M 11.16M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M
Spectrum Pharmaceuticals SPPI:US $ 25.51M 53.17M
Tg Therapeutics TGTX:US $ 231.79M 46.11M
Verastem VSTM:US $ 63.95M 17.26M
Vertex Pharmaceuticals VRTX:US $ 8702.2M 1102.1M
Ziopharm Oncology ZIOP:US $ 60.01M 8.24M